Fondazione Don Carlo Gnocchi Onlus   Report issue

Foundation Phase 2
Founded: Milan Italy (1951)

Organization Overview

First Clinical Trial
2004
NCT00742248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Fondazione Don Carlo Gnocchi Onlus | Fondazione Don C. Gnocchi - I.R.C.C.S. Santa Maria Nascente | IRCCS Don Carlo Gnocchi | IRCCS Fondazione Don Carlo Gnocchi | IRCCS S. Maria Nascente, Fondazione Don Carlo Gnocchi ONLUS

Active Ingredients

Drugs in Phase 2 Trials (1)

formoterol (foradil) (1 trial)

Drugs in Other Trials (7)

arginine (1 trial)

hyaluronic acid (1 trial)

lactobacillus casei (1 trial)

oxygen (1 trial)

silver (1 trial)

whey protein (1 trial)

zinc (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 8